| __timestamp | Summit Therapeutics Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 855506000 |
| Thursday, January 1, 2015 | 23943601 | 996170000 |
| Friday, January 1, 2016 | 23689111 | 1047690000 |
| Sunday, January 1, 2017 | 41006114 | 1324625000 |
| Monday, January 1, 2018 | 51379106 | 1416476000 |
| Tuesday, January 1, 2019 | 32705593 | 1754540000 |
| Wednesday, January 1, 2020 | 53274000 | 1829537000 |
| Friday, January 1, 2021 | 85352000 | 3051100000 |
| Saturday, January 1, 2022 | 51999000 | 2540300000 |
| Sunday, January 1, 2023 | 59471000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc. exemplify two distinct approaches to research and development (R&D) spending. Over the past decade, Vertex has consistently invested heavily in R&D, with expenditures peaking at approximately $3.16 billion in 2023, marking a staggering 270% increase since 2014. This commitment underscores Vertex's strategy to lead in drug discovery and development.
In contrast, Summit Therapeutics Inc. has maintained a more modest R&D budget, with spending reaching around $59 million in 2023. Despite this, Summit has shown a notable 280% increase in R&D investment since 2014, reflecting its dedication to innovation within its financial constraints.
This comparison highlights the diverse strategies companies employ to prioritize innovation, with Vertex's substantial investments contrasting with Summit's steady growth in R&D spending.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Vertex Pharmaceuticals Incorporated vs Veracyte, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Genmab A/S and Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Vericel Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation